Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
peptide |
| gptkbp:administeredBy |
subcutaneous implant
|
| gptkbp:approvedBy |
gptkb:European_Medicines_Agency
gptkb:U.S._Food_and_Drug_Administration |
| gptkbp:ATCCode |
D11AX06
|
| gptkbp:brand |
Scenesse
|
| gptkbp:CASNumber |
75921-69-6
|
| gptkbp:chemicalFormula |
C78H111N21O19
|
| gptkbp:developedBy |
Clinuvel Pharmaceuticals
|
| gptkbp:discoveredIn |
1990s
|
| https://www.w3.org/2000/01/rdf-schema#label |
afamelanotide
|
| gptkbp:improves |
melanin production
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
melanocortin 1 receptor agonist
|
| gptkbp:molecularWeight |
1646.9 g/mol
|
| gptkbp:reduces |
phototoxic reactions
|
| gptkbp:routeOfAdministration |
subcutaneous
|
| gptkbp:sideEffect |
nausea
fatigue headache injection site reaction |
| gptkbp:synonym |
Nle4-D-Phe7-α-MSH
|
| gptkbp:target |
melanocortin receptors
|
| gptkbp:usedFor |
gptkb:erythropoietic_protoporphyria
|
| gptkbp:bfsParent |
gptkb:Erythropoietic_protoporphyria
|
| gptkbp:bfsLayer |
6
|